# MITIGO

NDC: 66794-160
Generic name: Morphine Sulfate
Labeler / Manufacturer: Piramal Critical Care, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: EPIDURAL, INTRATHECAL
Marketing started: 20190225

FDA application: ANDA204393

## Active ingredients

- MORPHINE SULFATE: 200 mg/20mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66794-160"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66794-160
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=728f3d83-9a63-0c1f-e053-2a91aa0ac7db